"Designing Growth Strategies is in our DNA"

U.S. Blood Group Typing Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-matching Tests, and HLA Typing), By Technique (Serology Tests and Molecular Tests), By End-user (Hospital-based Laboratories and Independent Laboratories & Blood Banks), and Country Forecast, 2023-2030

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI108806

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Technological Advancements in Blood Group Typing Techniques
    2. Number of Blood Donations in the U.S.
    3. New Product Launches, By Key Players
    4. Key Industry Development: Mergers, Acquisitions, and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Blood Group Typing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Test Type
      1. ABO Tests
      2. Antigen Typing
      3. Antibody Screening
      4. Cross-matching Tests
      5. HLA Typing
    3. Market Analysis, Insights and Forecast – By Technique
      1. Serology Tests
      2. Molecular Tests
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospital-based Laboratories
      2. Independent Laboratories & Blood Banks
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Quotient Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. CareDx Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Illumina, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Merck KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Beckman Coulter, Inc. (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. QuidelOrtho Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Technological Advancements in Blood Group Typing Techniques
    2. Number of Blood Donations in the U.S.
    3. New Product Launches, By Key Players
    4. Key Industry Development: Mergers, Acquisitions, and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Blood Group Typing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Test Type
      1. ABO Tests
      2. Antigen Typing
      3. Antibody Screening
      4. Cross-matching Tests
      5. HLA Typing
    3. Market Analysis, Insights and Forecast – By Technique
      1. Serology Tests
      2. Molecular Tests
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospital-based Laboratories
      2. Independent Laboratories & Blood Banks
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Quotient Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. CareDx Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Illumina, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Merck KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Beckman Coulter, Inc. (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. QuidelOrtho Corporation
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Blood Group Typing Market Revenue Breakdown (USD Million, %), By Product, 2022 & 2030

Figure 2: U.S. Blood Group Typing Market Value Share (%), by Product, 2022 & 2030

Figure 3: U.S. Blood Group Typing Market Value Share (%), by Test Type, 2022 & 2030

Figure 4: U.S. Blood Group Typing Market Value Share (%), by Technique, 2022 & 2030

Figure 5: U.S. Blood Group Typing Market Value Share (%), by End User, 2022 & 2030

Figure 6: U.S. Blood Group Typing Market Share (%), By Company, 2022

Table 1: U.S. Blood Group Typing Market Revenue (USD Million) Forecast, by Product, 2019–2030

Table 2: U.S. Blood Group Typing Market Revenue (USD Million) Forecast, by Test Type, 2019–2030

Table 3: U.S. Blood Group Typing Market Revenue (USD Million) Forecast, by Technique, 2019–2030

Table 4: U.S. Blood Group Typing Market Revenue (USD Million) Forecast, by End-user, 2019–2030

U.S. Blood Group Typing Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports